InvestSMART

Ramsay Health Care Limited (ASX: RHC) - Share Price

Current share price for RHC : $44.150 0.04 (0.09%)+

Ramsay Health Care Limited (RHC), an ASX-listed company, provides quality healthcare in its core market in Australia, in the UK comprising two businesses Ramsay UK hospitals and Elysium mental health services, and in Europe through its 52.79% ownership of Ramsay Sante, which operates in France and Scandinavia.

RHC General Information +

ASX Code RHC
Website http://ramsayhealth.com
Industry/Sector Health Care Facilities
Market Cap ($M) 10,191
RHC Share Price $44.150
Day High $44.550
Day Low $43.920
Last Close $44.190
RHC Share Price Movement $0.04 ( 0.09% )
Prices as at 13:56, 31 Jul 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

How RHC Plays a Part in Australian ETF Strategies

As one of Australia's largest companies by market capitalisation, RHC is held across 34 ETFs spanning strategies that include health care facilities exposure . Its weighting in those funds means performance can have an outsized influence - when RHC moves, funds like M1DS, GIVE, MVE, VSO and MVW that hold it can move with it.

For more concentrated exposure, ETFs such as M1DS (Paradice Australian Mid Cap Fund Active ETF) allocate about 3.5% to RHC , while the average exposure across all 34 ETFs that hold it is around 0.8% .

Top ETF holdings

RHC Direct vs. ETF Alternatives

How does holding Ramsay Health Care Limited (RHC) shares directly compare to ETFs that include it?

RHC Direct
M1DS
CBOE
GIVE
ASX
MVE
ASX
VSO
ASX
MVW
ASX
Holdings 1 company 44 holdings 10 holdings 50 holdings 193 holdings 74 holdings
Risk Profile High Medium Medium High Medium Medium
Asset Class Share Equities Equities Equities Equities Equities
Annual Cost Brokerage only - 0.65% p.a. 0.45% p.a. 0.3% p.a. 0.35% p.a.
Approx. Yield - - 5.6% 2.69% 4.91% 3.4%
Latest Franking 100% - 21.82% 48% 22.17% 54%

Yields and costs are approximate. ETF yields reflect the fund's dividend distributions, not RHC's direct yield.

Ramsay Health Care Limited (RHC) ETFs

34 ETFs hold Ramsay Health Care Limited (RHC).

Ramsay Health Care Limited (RHC) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield
Result 42.5¢ 100% 9 Mar 2026 26 Mar 2026 - - -
HFResult 40¢ 100% 3 Sep 2025 25 Sep 2025 - - -
Result 40¢ 100% 6 Mar 2025 27 Mar 2025 - - -

See all dividends from Ramsay Health Care Limited (RHC) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Ramsay Health Care Limited (RHC) price-sensitive announcements

RHC - 2026 Half Year Results Presentation
Ramsay Health Care Limited's 2026 Half Year Results Presentation highlighted a 7.3% increa
Ramsay Health Care Limited (RHC)
26 Feb 2026 | 8:24 AM
RHC - 2026 Half Year Results Announcement
Ramsay Health Care Limited announced their 2026 Half Year Results, highlighting a strong p
Ramsay Health Care Limited (RHC)
26 Feb 2026 | 8:23 AM
RHC - 2026 Half Year Financial Report
Ramsay Health Care Limited's 2026 Half Year Financial Report shows significant financial p
Ramsay Health Care Limited (RHC)
26 Feb 2026 | 8:23 AM
RHC - Update on Strategic Review of Ramsay Sante
Ramsay Health Care Limited (ASX:RHC) has announced a strategic decision to separate its 52
Ramsay Health Care Limited (RHC)
20 Feb 2026 | 8:23 AM

Ramsay Health Care Limited (RHC) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
Ramsay Health Care Limited (RHC)
ORDINARY FULLY PAID
Health Care $10,191 Ramsay Sante - Refinancing and CMD 23 Jul 2026 8:25AM $42.760 $44.150 risen by 3.25%
Ramsay Health Care Limited (RHC)
ORDINARY FULLY PAID
Health Care $10,191 Change in substantial holding 8 Jul 2026 4:31PM $43.050 $44.150 risen by 2.56%
Ramsay Health Care Limited (RHC)
ORDINARY FULLY PAID
Health Care $10,191 Notification of cessation of securities - RHC 6 Jul 2026 11:38AM $43.930 $44.150 risen by 0.50%
Ramsay Health Care Limited (RHC)
ORDINARY FULLY PAID
Health Care $10,191 Ceasing to be a substantial holder 3 Jul 2026 4:20PM $44.160 $44.150 fallen by 0.02%
Ramsay Health Care Limited (RHC)
ORDINARY FULLY PAID
Health Care $10,191 Becoming a substantial holder 2 Jun 2026 2:23PM $36.310 $44.150 risen by 21.59%
Ramsay Health Care Limited (RHC)
ORDINARY FULLY PAID
Health Care $10,191 RAMSAY SANTE - Results for 9 months to 31 March 2026 8 May 2026 8:21AM $37.610 $44.150 risen by 17.39%

RHC Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2026F $444.40 $192.92 55.60% 17.75 125.00 3.65% 100.0%
2025F $285.51 $123.94 2.00% 27.63 81.00 2.37% 100.0%
2024A $278.00 $121.45 12.10% 42.68 65.00 1.25% 100.0%

RHC Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2024 A 2025 F 2026 F 2024 A 2025 F 2026 F 2024 A 2025 F 2026 F
Regis Healthcare Limited (REG) $1,920M -6.7687 0.0841 0.3125 35.8554 33.0729 25.1984 2.55% 2.74% 3.57%
Ramsay Health Care Limited (RHC) $10,217M 0.2153 -0.2767 0.4017 28.1713 38.9510 27.7875 1.81% 1.92% 2.35%

RHC Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.87 38.90 2.03 0.00
Market 0.59 17.40 1.61 1.01
Sector 0.71 19.60 1.58 1.77

RHC Directors

Name Position Start Date
Mr Natalie Davis Chief Executive Officer, Managing Director 2 Dec 2024
Ms Catriona Alison Deans Non-Executive Director 15 Nov 2018
Mr Michael Stanley Siddle Non-Executive Director 26 May 1975
Mr Craig Milton Drummond Non-Executive Director 1 Jul 2025
Ms Helen Kurincic Non-Executive Director 1 Mar 2024
Ms Karen Lee Collett Penrose Non-Executive Director 1 Mar 2020
Mr Steven Andrew Sargent Non-Executive Director 25 Nov 2021
Ms Claudia Ricarda Rita Sussmuth Dyckerhoff Non-Executive Director 30 Oct 2018
Mr David Ingle Thodey Non-Executive Director, Non-Executive Chairman 28 Nov 2017

Ramsay Health Care Limited (RHC) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
26 Mar 2026 SARGENT, Steven Buy Indirect Shares 619 $40.355 $24,979.745
25 Mar 2026 DRUMMOND, Craig Buy Direct Shares 15,000 $40.186 $602,788.500
24 Mar 2026 PENROSE, Karen Buy Indirect Shares 701 $39.409 $27,625.429

See all changes in directors' interest & trades for Ramsay Health Care Limited (RHC) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

RHC Management

Name Position
Michael Hirner Acting Group Executive Finance
Henrietta Rowe Company Secretary,Group General Counsel
Brindan Suresh Group Executive Health and Strategy
Colleen Harris Group Executive People and Sustainability
Pascal Roche Managing Director Ramsay Sante
Nick Costa Managing Director UK Hospitals, Acting Managing Director Elysium

RHC Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Ramsay Health Care Limited (RHC). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
40,473,494 (17.50%) Paul Ramsay Holdings Pty Ltd
13,428,365 (5.80%) Allan Gray Australia Pty Ltd
11,545,374 (5%) State Street Corporation and subsidiaries

RHC Calendar of Events

Date Event
25 February 2027 Report (Interim)
15 October 2026 Report (Annual)
18 September 2026 Report (Annual)
27 August 2026 Report (Prelim)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.